Literature DB >> 23794006

As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio.

Ahmet Ahsen1, Memnune Sena Ulu, Seref Yuksel, Kasım Demir, Mukremin Uysal, Mujgan Erdogan, Gursel Acarturk.   

Abstract

Familial Mediterranean fever (FMF), which is an autosomal recessive disease, is characterised by recurrent febrile episodes in association with peritonitis, pleuritis and arthritis and has ongoing subclinical inflammation during attack-free period. In this study, we aimed to investigate the relationship between FMF with neutrophil-to-lymphocyte ratio (NLR), which is determined in many chronic inflammations as a new potential inflammatory mediator. We included 62 patients and 41 healthy subjects who were similar in terms of age and sex. We found that the NLR values of the patients were significantly higher than those of the control group, and C-reactive protein values were correlated with NLR. Another finding was the NLR values were significantly higher in the FMF patient with M694V mutation than with other mutations. As a result, NLR might be used in the FMF patient as an indicator of the subclinical inflammation, and the FMF patients with M694V mutation should be followed up closely because of increased subclinical inflammation risk.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23794006     DOI: 10.1007/s10753-013-9675-2

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  45 in total

1.  Acute phase response and evolution of familial Mediterranean fever.

Authors:  M Tunca; G Kirkali; M Soytürk; S Akar; M B Pepys; P N Hawkins
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

Review 2.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

Review 3.  Familial mediterranean fever in Arabs.

Authors:  Hatem El-Shanti; Hasan Abdel Majeed; Mohammed El-Khateeb
Journal:  Lancet       Date:  2006-03-25       Impact factor: 79.321

Review 4.  Familial Mediterranean fever.

Authors:  Fatos Onen
Journal:  Rheumatol Int       Date:  2005-11-10       Impact factor: 2.631

5.  Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis.

Authors:  A Mimouni; N Magal; N Stoffman; T Shohat; A Minasian; M Krasnov; G J Halpern; J I Rotter; N Fischel-Ghodsian; Y L Danon; M Shohat
Journal:  Pediatrics       Date:  2000-05       Impact factor: 7.124

6.  The leucocyte count: correlates and relationship to coronary risk factors: the CARDIA study.

Authors:  G D Friedman; I Tekawa; R H Grimm; T Manolio; S G Shannon; S Sidney
Journal:  Int J Epidemiol       Date:  1990-12       Impact factor: 7.196

7.  Down-regulation of adiponectin in patients with familial Mediterranean fever during attack-free period.

Authors:  Vedat Gerdan; Ismail Sari; Didem Kozacı; Fatos Önen; Feride Yüksel; Ozgül Soysal; Dilek Solmaz; Necati Günay; Nurullah Akkoc; Servet Akar
Journal:  Rheumatol Int       Date:  2011-08-30       Impact factor: 2.631

8.  Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.

Authors: 
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

9.  Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.

Authors:  A Duzova; A Bakkaloglu; N Besbas; R Topaloglu; S Ozen; F Ozaltin; Y Bassoy; E Yilmaz
Journal:  Clin Exp Rheumatol       Date:  2003 Jul-Aug       Impact factor: 4.473

10.  Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children.

Authors:  Seza Ozen; Erkan Demirkaya; Gayane Amaryan; Isabelle Koné-Paut; Adem Polat; Pat Woo; Yosef Uziel; Consuelo Modesto; Martina Finetti; Pierre Quartier; Efimia Papadopoulou-Alataki; Sulaiman M Al-Mayouf; Giovanna Fabio; Romina Gallizzi; Luca Cantarini; Joost Frenkel; Susan Nielsen; Michael Hofer; Antonella Insalaco; C Acikel; Huri Ozdogan; Alberto Martini; Nicolino Ruperto; Marco Gattorno
Journal:  Ann Rheum Dis       Date:  2013-03-05       Impact factor: 19.103

View more
  46 in total

1.  Neutrophil-lymphocyte ratio in patients with familial Mediterranean fever.

Authors:  Mehmet Celikbilek; Serkan Dogan; Lutfi Akyol; Elif Borekci; Gokmen Zararsiz; Mustafa Kozan; Ilhan Gunaydin
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

2.  Assessing disease severity and activity in patients with familial Mediterranean fever.

Authors:  S Kapoor
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

3.  The Importance of Neutrophil-to-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease.

Authors:  Erdal İn; Mutlu Kuluöztürk; Önsel Öner; Figen Deveci
Journal:  Turk Thorac J       Date:  2016-04-01

4.  The relationship between inflammatory marker levels and pulmonary tuberculosis severity.

Authors:  Ozlem Abakay; Abdurrahman Abakay; Hadice Selimoglu Sen; Abdullah C Tanrikulu
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

5.  Assessment of Neutrophil- Lymphocyte and Platelet- Lymphocyte Ratios in Ankylosing Spondylitis.

Authors:  İsmail Boyraz; Bünyamin Koç; Sirzat Çoğalgil
Journal:  Arch Rheumatol       Date:  2016-05-06       Impact factor: 1.472

6.  Predictive value of the neutrophil-to-lymphocyte ratio and hemoglobin insystemic lupus erythematosus.

Authors:  Haitao Yu; Lili Jiang; Liqiong Yao; Chao Gan; Xinwen Han; Ruiqi Liu; Na Su
Journal:  Exp Ther Med       Date:  2018-06-13       Impact factor: 2.447

7.  Neutrophil-Lymphocyte Ratio Connected to Treatment Options and Inflammation Markers of Ankylosing Spondylitis.

Authors:  Ferhat Gökmen; Ayla Akbal; Hatice Reşorlu; Esra Gökmen; Mustafa Güven; Adem Bozkurt Aras; Gökhan Erbağ; Erkam Kömürcü; Erdem Akbal; Murat Coşar
Journal:  J Clin Lab Anal       Date:  2014-05-21       Impact factor: 2.352

8.  Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis.

Authors:  Belkıs Nihan Coşkun; Mustafa Ferhat Öksüz; Selime Ermurat; Ayşe Nur Tufan; Nurdan Oruçoğlu; Akif Doğan; Ediz Dalkılıç; Yavuz Pehlivan
Journal:  Eur J Rheumatol       Date:  2014-09-01

9.  Red cell distribution width and neutrophil-to-lymphocyte ratio as a predictive factor in treatment of pediatric patients with burns.

Authors:  Metin Gunduz; Ilhan Ciftci; Ahmet Cinar Yasti; Ahmet Guven
Journal:  Int J Burns Trauma       Date:  2020-08-15

10.  Neutrophil-Lymphocyte Ratio in Patients with Adenoidectomy.

Authors:  Serhan Derin; Selvet Erdogan; Murat Sahan; Hatice Topal; Hamdi Sozen
Journal:  J Clin Diagn Res       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.